Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting

v3.10.0.1
Segment Reporting
 3 Months Ended
Sep. 30, 2018
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]
16.
Segment Reporting
 
In accordance with FASB ASC 280, “
Segment Reporting
,” the Company discloses financial and descriptive information about its reportable segments. The Company operates in two segments, iBio, Inc. and iBio CDMO. These segments are components of the Company about which separate financial information is available and regularly evaluated by the chief operating decision maker in deciding how to allocate resources and in assessing performance. Please note that certain totals may not sum due to rounding.
 
Three Months Ended September 30, 2018 (in thousands)
 
iBio, Inc.
 
 
iBio CDMO
 
 
Eliminations
 
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenues – external customers
 
$
45
 
 
$
-
 
 
$
-
 
 
$
45
 
Revenues – intersegment
 
 
364
 
 
 
57
 
 
 
(421
)
 
 
-
 
Research and development
 
 
558
 
 
 
587
 
 
 
(21
)
 
 
1,124
 
General and administrative
 
 
1,037
 
 
 
2,202
 
 
 
(368
)
 
 
2,871
 
Operating loss
 
 
(1,185
)
 
 
(2,765
)
 
 
-
 
 
 
(3,950
)
Interest expense
 
 
-
 
 
 
(476
)
 
 
-
 
 
 
(476
)
Interest and other income
 
 
23
 
 
 
4
 
 
 
-
 
 
 
27
 
Consolidated net loss
 
 
(1,162
)
 
 
(3,237
)
 
 
-
 
 
 
(4,399
)
Total assets
 
 
40,131
 
 
 
15,505
 
 
 
(12,740
)
 
 
42,896
 
Fixed assets, net
 
 
4
 
 
 
24,977
 
 
 
-
 
 
 
24,981
 
Intangible assets, net
 
 
1,554
 
 
 
-
 
 
 
-
 
 
 
1,554
 
Depreciation expense
 
 
1
 
 
 
359
 
 
 
-
 
 
 
360
 
Amortization of intangible assets
 
 
83
 
 
 
-
 
 
 
-
 
 
 
83
 
  
Three Months Ended September 30, 2017 (in thousands)
 
iBio, Inc.
 
 
iBio CDMO
 
 
Eliminations
 
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenues – external customers
 
$
84
 
 
$
38
 
 
$
-
 
 
$
122
 
Revenues – intersegment
 
 
301
 
 
 
210
 
 
 
(511
)
 
 
-
 
Research and development
 
 
618
 
 
 
484
 
 
 
(117
)
 
 
985
 
General and administrative
 
 
1,099
 
 
 
1,698
 
 
 
(299
)
 
 
2,498
 
Operating loss
 
 
(1,332
)
 
 
(2,029
)
 
 
-
 
 
 
(3,361
)
Interest expense
 
 
-
 
 
 
(480
)
 
 
-
 
 
 
(480
)
Interest and other income
 
 
12
 
 
 
2
 
 
 
-
 
 
 
14
 
Consolidated net loss
 
 
(1,321
)
 
 
(2,506
)
 
 
-
 
 
 
(3,827
)
Total assets
 
 
18,810
 
 
 
27,485
 
 
 
(12,862
)
 
 
33,433
 
Fixed assets, net
 
 
7
 
 
 
25,261
 
 
 
-
 
 
 
25,268
 
Intangible assets, net
 
 
1,757
 
 
 
-
 
 
 
-
 
 
 
1,757
 
Depreciation expense
 
 
1
 
 
 
337
 
 
 
-
 
 
 
338
 
Amortization of intangible assets
 
 
85
 
 
 
-
 
 
 
-
 
 
 
85